A Phase I Study of a Novel MDM2 Inhibitor Alrizomadlin (APG-115) in TP53 Wild-Type Salivary Gland Cancers
Targeted capture short-read sequencing of tumor and normal DNA pairs with a panel which includes 7814 high-density probes covering the coding exons of 233 host genes.